These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151 [TBL] [Abstract][Full Text] [Related]
3. Escherichia coli resistant to ampicillin/sulbactam. Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964 [TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS; Tosin I; Sejas L; Miranda E Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [TBL] [Abstract][Full Text] [Related]
5. Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible Noguchi T; Matsumura Y; Kanahashi T; Tanaka M; Tsuchido Y; Matsumura T; Nakano S; Yamamoto M; Nagao M; Ichiyama S Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455244 [TBL] [Abstract][Full Text] [Related]
6. Activity of beta-lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella, Haemophilus, and Staphylococcus. Girard AE; Schelkly WU; Murphy KT; Sawyer PS Am J Vet Res; 1987 Dec; 48(12):1678-83. PubMed ID: 3501686 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production. Chao HP; Ho SW; Luh KT; Hsieh WC Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003 [No Abstract] [Full Text] [Related]
8. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria]. González C; García A; Urrea R; del Solar E; Bello H; Zemelman R Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase]. Moittie D; Simonet M; Veron M Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of susceptibility testing methods for ampicillin-sulbactam using a panel of beta-lactamase-producing bacteria. Siu LK; Lo JY; Cheng WL; Ho PL; Ng WS; Chau PY APMIS; 1999 Jul; 107(7):703-8. PubMed ID: 10440070 [TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1993 Sep; 46(9):781-93. PubMed ID: 8254898 [TBL] [Abstract][Full Text] [Related]
15. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group]. Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H; Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526 [TBL] [Abstract][Full Text] [Related]
16. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chin NX; McElrath MJ; Neu HC Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139 [TBL] [Abstract][Full Text] [Related]
17. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin]. Acar N; Diri MC; Türkyilmaz FR Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals. Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890 [TBL] [Abstract][Full Text] [Related]
19. Bacteriological studies with ampicillin/sulbactam on selected strains of gram-negative bacteria. Bello H; del Solar E; González C; Garcia A; Urrea R; Zemelman R Diagn Microbiol Infect Dis; 1988 Oct; 11(2):109-15. PubMed ID: 3067960 [TBL] [Abstract][Full Text] [Related]
20. Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase. Livermore DM J Antimicrob Chemother; 1992 Feb; 29(2):222-4. PubMed ID: 1506339 [No Abstract] [Full Text] [Related] [Next] [New Search]